Nantes-based biotech company XENOTHERA, which is developing a proprietary “glyco-humanized” antibody technology platform based on dual expertise in genetics and immunology, announced today that it has completed a €20 million financing round. This new round of financing is financed by the current shareholders, including Didier Rousseau, FAMM’s President and Founder, and welcomes a number of new investors, in particular the European fund EIC Fund, the holding company Nabuboto, the French fund Anaxago Capital (Objectif Innovation 18), and the social security group Malakoff Humanis (a French company that provides financial services to the public). The capital increase will enable the Nantes-based company, which has become better known through the development of its anti-COVID-19 treatment, XAV-19, to accelerate its growth and develop its product portfolio.

In just a few years, the Nantes-based company has brought two products to the clinical stage, LIS1, an immunosuppressant for transplantation, and XAV-19, an anti-SARS-CoV-2 antibody. In addition, it is developing XAB05, a preventive treatment for infections by multi-resistant bacteria, and a very promising portfolio in oncology.

TOOVALU _ Fundraising

Publisher of an innovative software solution that helps companies to manage their climate and CSR strategy, with their extra-financial indicators at all levels of the company, Toovalu opens its capital to a group of investors / entrepreneurs committed to accelerating the deployment of the solution. This fund raising will allow the company to accelerate its development, to better respond to the strong demand by intensifying R&D and by recruiting new talents.

“To offer solutions that meet the climate challenges and make the 1.5°C Trajectory possible! It will also be the opportunity to expand our offer and our impact to more companies such as Impact Observer or mission company”.

Marie GABORIT _ Managing Partner TOOVALU. April 2020.

Ecovelo _ Fundraising

Nantes, May 05, 2020 – Ecovelo (Human concept SAS) closes a €2M financing round with Banque des Territoires, GO CAPITAL (via the fund OUEST VENTURES III) and Parthal. The operation is coupled with a bank debt raising of 1.3 M€. Thanks to this financing, the Nantes-based company, which designs and supplies innovative turnkey hybrid self-service bicycle solutions, intends to accelerate its development with local authorities and transport operators.

“We have found our customers, proven our value and our difference to better meet the needs of small and medium-sized communities. We have a reassuring business model and the right partners to support us in this adventure. We feel a certain urgency to deploy our solutions. This financing operation is in line with our strategy and consolidates our history, I am delighted.”

Sebastien BOURBOUSSON. CEO Ecovelo (Human Concept). May 2020

Finple _ M&A

Finple welcomes the Consultim Group and its majority shareholder BlackFin Capital Partners to its capital. The Consultim Group has acquired a majority stake in Finple, which has become Finple by Consultim.

“In a favorable environment, we wanted to be backed by a group that would enable us to accelerate our growth in the coming years. Our goal is to finance the real economy to the tune of €100 million per year by 2022. It was to meet this ambition that we decided to join forces with the Consultim Group. We share the group’s entrepreneurial values and are keen to offer investors new asset classes.” Thomas DEROSNE. President FINPLE

Zéphyr & Borée _ Fundraising

“We are proud to announce the entry of SOPER, the investment fund of Jean-Michel Germa, and Francis Vallat to the capital of Zéphyr & Borée. SOPER has an expertise in technologies such as batteries, hydrogen, solar energy, biofuels that Zéphyr&Borée wishes to study to implement as a complement the wind propulsion. This fund raising coupled with the expertise of Jean-Michel and Francis will allow Zéphyr&Borée to accelerate the deployement of its projects aiming the decarbonation of shipping.”

Nils Joyeux. CEO Zephir & Borée / December 2019.